Surgery in advanced epithelial ovarian cancer

Comment

M S Piver. J Clin Oncol. 2001.

. 2001 Apr 15;19(8):2364.

No abstract available

Comment on

The impact of aggressive debulking surgery and cisplatin-based chemotherapy on progression-free survival in stage III and IV ovarian carcinoma.
Piver MS, Lele SB, Marchetti DL, Baker TR, Tsukada Y, Emrich LJ. Piver MS, et al. J Clin Oncol. 1988 Jun;6(6):983-9. doi: 10.1200/JCO.1988.6.6.983. J Clin Oncol. 1988. PMID: 3373267
Phase II feasibility study of sequential couplets of Cisplatin/Topotecan followed by paclitaxel/cisplatin as primary treatment for advanced epithelial ovarian cancer: a National Cancer Institute of Canada Clinical Trials Group Study.
Hoskins P, Eisenhauer E, Vergote I, Dubuc-Lissoir J, Fisher B, Grimshaw R, Oza A, Plante M, Stuart G, Vermorken J. Hoskins P, et al. J Clin Oncol. 2000 Dec 15;18(24):4038-44. doi: 10.1200/JCO.2000.18.24.4038. J Clin Oncol. 2000. PMID: 11118464 Clinical Trial.